Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04202640
Other study ID # PRESSODOU-1809
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date May 27, 2020
Est. completion date December 7, 2023

Study information

Verified date December 2023
Source Centre Oscar Lambret
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effectiveness of mechanical stimulation technique compared to massages on pain level and functional discomfort (on the mobility of the shoulder) after 6 months, in breast cancer needing physiotherapy, following a total mastectomy and exploratory axillary surgery.


Description:

A prospective, monocentric, randomized, open-labelled in two parallel groups study that evaluates the effectiveness of mechanical stimulation technique compared to massages on pain level and functional discomfort (on the mobility of the shoulder) after 6 months in breast cancer patients needing physiotherapy, following a total mastectomy and exploratory axillary surgery. Other objectives of the study include: - Evaluate the efficacy of mechanical stimulation technique compared to massages on pain and functional discomfort (on the mobility of the shoulder) 15 days after the end of physiotherapy. - Evaluate the impact of mechanical stimulation on the quality of life of patients, in comparison to those receiving massages


Recruitment information / eligibility

Status Terminated
Enrollment 80
Est. completion date December 7, 2023
Est. primary completion date December 7, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age > 18 years - Patient who had total mastectomy for a breast cancer or pre-cancerous lesions - Associated with axillary dissection or removal of the sentinel lymph nodes - Presenting with functional discomfort and/or pain at the control consultation, 3 weeks after the mastectomy and justifying the prescription of physiotherapy - Possibility to be treated by a physiotherapist who can carry out both techniques and accepts to perform either one of the techniques according to the randomized allocation of the treatment - Patient covered by the French social security regime - Signed and informed consent Exclusion Criteria: - Immediate breast reconstruction - Total bilateral mastectomy - Contraindication to mechanical stimulation technique - Patient who are planning to move houses in the next 6 months - Patients under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Mechanical Stimulation
The technique of mechanical stimulation alternates between compression and decompression of the treated area. It aims to reestablish a good blood circulation and lymphatic drainage.
Massages
Massages will be carried out according to a specific regime as specified in the study protocol. The massages will be done in 15 sessions of 30 minutes each, done twice a week and will consist of: One part muscle exercise One part skin work (drainage)

Locations

Country Name City State
France Centre Hospitalier Universitaire de Lille Lille
France Centre Oscar Lambret Lille Hauts-de- France

Sponsors (1)

Lead Sponsor Collaborator
Centre Oscar Lambret

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain level by a numerical scale Pain level will be evaluated using a numerical scale of pain 6 months after randomization
Primary Pain level by using Brief Pain Inventory Pain level will be evaluated using Brief Pain Inventory (BPI), there is no global score for this questionnaire, each item must be considered separately. 6 months after randomization
Primary Pain level by using QDN4 questionnaire Pain level will be evaluated using QDN4 questionnaire, which is a pain scale from 0 to 10. 6 months after randomization
Primary Mobility of the shoulders Will be evaluated using the Constant score based on the study by Constant CR, Murley AHG. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res 1987;(214):160-4.
Pain level, level of daily activities and physical mobility will be assessed with a a scale adapted according to the gender and the patients age.
6 months after randomization
Secondary Pain level by a numerical scale Pain level will be evaluated using a numerical scale of pain 15 days after the end of physiotherapy
Secondary Pain level by using Brief Pain Inventory Pain level will be evaluated using Brief Pain Inventory (BPI), there is no global score for this questionnaire, each item must be considered separately. 15 days after the end of physiotherapy
Secondary Pain level by using QDN4 questionnaire Pain level will be evaluated using QDN4 questionnaire, which is a pain scale from 0 to 10. 15 days after the end of physiotherapy
Secondary Mobility of the shoulders Will be evaluated using the Constant score based on the study by Constant CR, Murley AHG. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res 1987;(214):160-4.
Pain level, level of daily activities and physical mobility will be assessed with a a scale adapted according to the gender and the patients age.
15 days after the end of physiotherapy
Secondary Anxiety Will be evaluated using the Hospital Anxiety and Depression Scale (HADS) questionnaire. The questionnaire consists of a list of questions to determine the level of anxiety and depression experienced by the patients. Each question is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression:
A score equal to or less than 7 indicates no symptoms,
A score of 8 - 10 indicates a questionable symptoms,
A score of 11 and above confirms of the presence of anxiety and/or depression symptoms
at the baseline and 6 months after
Secondary Quality of Life (QoL) with EORTC-QLQ-C30 Will be evaluated using the EORTC-QLQ-C30 questionnaire. This questionnaire aim to assess the quality of life of cancer. It is composed of 30 questions.
In this questionnaire, the items are scored from 1-4, where 1 = not at all, 2 = a little, 3 = quite a bit and 4 = very much.
Only 2 items in the EORTC-QLQ-C30 questionnaire are scored from 1-7, where 1 is very poor and 7 is excellent.
at the baseline and 6 months after
Secondary Quality of Life (QoL) with EORTC-QLQ-BR23 Will be evaluated using the EORTC-QLQ-BR23 questionnaire. This questionnaire aim to assess the quality of life of cancer. It is composed of 23 questions.
In this questionnaire, the items are scored from 1-4, where 1 = not at all, 2 = a little, 3 = quite a bit and 4 = very much.
at the baseline and 6 months after
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2